Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR

被引:27
作者
Diel, Patrick [1 ]
Schiffer, Thorsten [4 ]
Geisler, Stephan [4 ]
Hertrampf, Torsten [1 ]
Mosler, Stephanie [1 ]
Schulz, Sven [2 ]
Wintgens, Karl Florian [3 ]
Adler, Michael [2 ]
机构
[1] German Sport Univ Cologne, Ctr Prevent Doping Res, Dept Mol & Cellular Sports Med, D-50933 Cologne, Germany
[2] Chimera Biotec GmbH, Dortmund, Germany
[3] Immundiagnost AG, Bensheim, Germany
[4] German Sport Univ Cologne, Inst Movement & Neurosci, D-50933 Cologne, Germany
关键词
Immuno PCR; Myostatin; Myostatin propeptide; Follistatin; Doping; Myostatin inhibitor; Androgens; HYPERTROPHY; ASSAY; MASS; QUANTIFICATION; PROTEINS; STRENGTH; EXERCISE; WOMEN; GENE; MICE;
D O I
10.1016/j.mce.2010.08.015
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Myostatin propeptide (MYOPRO) and follistatin (FOLLI) are potent myostatin inhibitors. In this study we analysed effects of training and androgens on MYOPRO and FOLLI concentrations in blood and skeletal muscle using Immuno PCR. Young healthy males performed either a 3-month endurance training or a strength training. Blood and biopsy samples were analysed. Training did not significantly affect MYOPRO and FOLLI concentrations in serum and muscle. To investigate whether total skeletal muscle mass may affect circulating MYOPRO and FOLLI levels, blood samples of tetraplegic patients, untrained volunteers and bodybuilders were analysed. MYOPRO was significantly increased exclusively in the bodybuilder group. In orchiectomised rats MYOPRO increased in blood and muscle after treatment with testosterone. In summary our data demonstrate that moderate training does not affect the concentrations of MYOPRO to FOLLI. In contrast androgen treatment results in a significant increase of MYOPRO in skeletal muscle and serum. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 30 条
[1]
Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samples [J].
Adler, M ;
Langer, M ;
Witthohn, K ;
Wilhelm-Ogunbiyi, K ;
Schöffski, P ;
Fumoleau, P ;
Niemeyer, CM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (05) :972-982
[2]
A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins [J].
Adler, M ;
Wacker, R ;
Niemeyer, CM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) :240-250
[3]
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity [J].
Amthor, Helge ;
Otto, Anthony ;
Vulin, Adeline ;
Rochat, Anne ;
Dumonceaux, Julie ;
Garcia, Luis ;
Mouisel, Etienne ;
Hourde, Christophe ;
Macharia, Raymond ;
Friedrichs, Melanie ;
Relaix, Frederic ;
Zammit, Peter S. ;
Matsakas, Antonios ;
Patel, Ketan ;
Partridge, Terence .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (18) :7479-7484
[4]
Muscle strength and flexibility characteristics of people displaying excessive medial knee displacement [J].
Bell, David R. ;
Padua, Darin A. ;
Clark, Michael A. .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (07) :1323-1328
[5]
Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[6]
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology [J].
Bogdanovich, S ;
Perkins, KJ ;
Krag, TOB ;
Whittemore, SA ;
Khurana, TS .
FASEB JOURNAL, 2005, 19 (06) :543-549
[7]
The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration [J].
Diel, P. ;
Friedel, A. ;
Geyer, H. ;
Kamber, M. ;
Laudenbach-Leschowsky, U. ;
Schaenzer, W. ;
Schleipen, B. ;
Thevis, M. ;
Vollmer, G. ;
Zierau, O. .
TOXICOLOGY LETTERS, 2008, 177 (03) :198-204
[8]
DIEL P, 2008, MOL CELL ENDOCRINOL, V291, P1004
[9]
siRNAs targeting mouse myostatin [J].
Furalyov, V. A. ;
Kravchenko, I. V. ;
Khotchenkov, V. P. ;
Popov, V. O. .
BIOCHEMISTRY-MOSCOW, 2008, 73 (03) :342-345
[10]
GROBET L, 1997, EUR J APPL PHYSL, V101, P473